Beetroot trial reports blood-marker changes in coronary artery disease
A secondary analysis found changes in fatty-acid and oxidative-stress measurements, but its abstract does not clearly identify the comparisons behind those changes.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Among people with chronic coronary artery disease, this secondary analysis reported changes in blood fatty acids and markers related to oxidative stress after beetroot capsules, with additional changes in a beetroot–vitamin C group. Because the abstract leaves the reference comparisons unclear, it does not establish how either supplement performed against placebo or against each other.
The abstract does not clarify whether reported changes are within-group or placebo-adjusted. It also omits doses and does not report patient outcomes, limiting conclusions about clinical benefit or the added value of vitamin C.
What changed in the blood
The study examined fatty-acid profiles and several blood markers. It reported a decrease in myeloperoxidase with beetroot and changes in fatty acids and total oxidant status in the group also receiving vitamin C.
Limits of laboratory outcomes
The analysis addresses laboratory measurements in people already diagnosed with coronary artery disease. Those measurements do not establish whether participants had fewer symptoms or cardiovascular events, or whether any changes persisted after treatment.
The original publication
Effect of Beetroot Extract Supplementation on Serum Fatty Acid Profiles and Oxidative Stress Markers in Chronic Coronary Artery Disease Patients: A Secondary Analysis of a Randomized Controlled Trial.
Mansouri-Baseri A, Moohebati M, Bahrami LS et al.
Biomed Res Int · 2025
- PubMed ID
- 41473738
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.